HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD – Trademark Portfolio

Entity Type: 99

HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TEBAS. The owner is based in Xinmi, Henan.

5F,bldg71,Core City Fashion Enterprise Fengshang Street,

Quliang Town

Xinmi, Henan 450000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

TEBAS
TEBAS
Registered 2022

Trademark Classifications

HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD have?

HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD file in?

HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD's most well-known trademarks?

HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD's registered trademark portfolio includes well-known marks such as TEBAS. These are among 1 currently registered trademark in the portfolio.

What is HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD's trademark registration success rate?

HENAN LIJITANG MEDICAL TECHNOLOGY CO.,LTD has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.